Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1998, p. 3567-3573, Vol. 36, No. 12
Division of Infectious Diseases, Vanderbilt
University School of Medicine, Nashville, Tennessee
37232-2605,1 and
Department of Veterans
Affairs Medical Center, Nashville, Tennessee 372122
Received 7 May 1998/Returned for modification 17 August
1998/Accepted 23 September 1998
Guillain-Barré syndrome (GBS), a neurologic disease
characterized by acute paralysis, is frequently preceded by
Campylobacter jejuni infection. Serotype O19 strains are
overrepresented among GBS-associated C. jejuni isolates. We
previously showed that all O19 strains tested were closely related to
one another by randomly amplified polymorphic DNA (RAPD) and
restriction fragment length polymorphism analyses. RAPD analysis
demonstrated a 1.4-kb band in all O19 strains tested but in no non-O19
strains. We cloned this O19-specific band; nucleotide sequence analysis
revealed a truncated open reading frame with significant homology to
DNA gyrase subunit B (gyrB) of Helicobacter
pylori. PCR using the random primer and a primer specific for
gyrB showed that in non-O19 strains, the random primer did
not recognize the downstream gyrB binding site. The regions
flanking each of the random primer binding sites were amplified by
degenerate PCR for further sequencing. Although the random primer had
several mismatches with the downstream gyrB binding site, a
single nucleotide polymorphism 6 bp upstream from the 3' terminus was
found to distinguish O19 and non-O19 strains. PCR using 3'-mismatched
primers based on this polymorphism was designed to differentiate O19
strains from non-O19 strains. When a total of 42 (18 O19 and 24 non-O19) strains from five different countries were examined, O19
strains were distinguishable from non-O19 strains in each case. This
PCR method should permit identification of O19 C. jejuni strains.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Differentiation of Campylobacter jejuni
Serotype O19 Strains from Non-O19 Strains by PCR
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Vanderbilt University School of Medicine, A-3310
Medical Center North, Nashville, TN 37232-2605. Phone: (615) 322-2035. Fax: (615) 343-6160. E-mail:
Martin.Blaser{at}mcmail.vanderbilt.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|